摘要
Objective To explore the value of combined detection of serum recombinant neuregulinl(NRG1),methylglyoxal(MG)and high mobility group protein B1(HMGB1)in diabetic peripheral neuropathy(DPN).Methods 240 type 2 diabetes mellitus(T2DM)patients hospitalized in the first affiliated hospital of Suzhou University from January 2019 to December 2020 were selected and divided into simple T2DM group(zi=108)and combined DPN group(DPN,n=132).
作者
陈旖婷
CHEN Yiting(Dept Endocrinol,1st Affil Hosp,Suzhou Univ,Suzhou 215000)
